type 2 diabetes semaglutide Ozempic® (semaglutide) GLP-1 RA for Oral Semaglutide and Cardiovascular Outcomes

The SmPC classifies nausea and diarrhoea as 'very common' (affecting more than 1 in 10 patients), while abdominal pain, abdominal distension, vomiting, flatulence and dyspepsia are classified as 'common' (affecting between 1 in 10 and 1 in 100 patients)

Free radicals can damage cells and DNA if left unchecked, resulting in issues such as: Increased signs of aging (such as wrinkled or dry skin) Headaches Low energy levels Increased risk of illness Lack of mental clarity Joint pain Fatigue Antioxidants, such as glutathione, rid the body of free radicals before they can do too much harm

Preclinical studies have investigated the effects of semaglutide or other GLP1R agonizts on nicotine, alcohol, cocaine or opioids [20,21,22,23]

GHK-Cu in the Broader Anti-Aging Peptide Landscape GHK-Cu is often used alongside other anti-aging peptides for synergistic effects